³ÉÈËÓ°Òô

Legal News

ABPI warns statutory scheme consultation threatens UK pharmaceutical investment

Published on: 09 May 2025
Published by LNB News

LNB News 09/05/2025

Document Information

Issue Date: 09 May 2025

Published Date: 09 May 2025

Jurisdiction(s): England, Northern Ireland, Scotland and Wales

Article summary

The Association of the British Pharmaceutical Industry (ABPI) has published its response to the Department of Health and Social Care's March 2025 consultation on increasing statutory scheme payment rates for branded medicines. The consultation proposes raising rates from 15.5% to 32.2% of NHS sales for the second half of 2025. ABPI warns these rates, alongside existing Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) payments, significantly exceed similar mechanisms in France (5.7%) and Germany (7%), potentially undermining UK pharmaceutical investment.

Popular documents